<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title></journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2014.2487</article-id>
<article-id pub-id-type="publisher-id">ol-08-05-1947</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>YONG</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref><xref rid="fn1-ol-08-05-1947" ref-type="author-notes">*</xref></contrib>
<contrib contrib-type="author">
<name><surname>GUO</surname><given-names>QINHAO</given-names></name><xref rid="af2-ol-08-05-1947" ref-type="aff">2</xref><xref rid="fn1-ol-08-05-1947" ref-type="author-notes">*</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHAO</surname><given-names>YAN</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>JIEJING</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>SHUWEI</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>JUN</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>SUN</surname><given-names>YUEMING</given-names></name><xref rid="af1-ol-08-05-1947" ref-type="aff">1</xref><xref ref-type="corresp" rid="c1-ol-08-05-1947"/></contrib></contrib-group>
<aff id="af1-ol-08-05-1947">
<label>1</label>Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China</aff>
<aff id="af2-ol-08-05-1947">
<label>2</label>Department of Obstetrics and Gynecology, Northern Jiangsu Province Hospital, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China</aff>
<author-notes>
<corresp id="c1-ol-08-05-1947">Correspondence to: Dr Yueming Sun, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210000, P.R. China, E-mail: <email>jssym@vip.sina.com</email></corresp><fn id="fn1-ol-08-05-1947">
<label>*</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>08</month>
<year>2014</year></pub-date>
<volume>8</volume>
<issue>5</issue>
<fpage>1947</fpage>
<lpage>1952</lpage>
<history>
<date date-type="received">
<day>03</day>
<month>03</month>
<year>2014</year></date>
<date date-type="accepted">
<day>23</day>
<month>07</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Long non-coding RNAs (lncRNAs) are novel regulators in cancer biology. BRAF-activated lncRNA (BANCR) is overexpressed in melanoma and has a potential functional role in melanoma cell migration. However, little is known about the role of BANCR in the development of papillary thyroid carcinoma (PTC). In the present study, BANCR expression was examined in six pairs of PTC and matched adjacent normal tissues. The results revealed that BANCR levels were significantly higher in the PTC tissues and PTC IHH-4 cells compared with the normal controls. Knockdown of BANCR in the IHH-4 cells inhibited proliferation and increased apoptosis of the cells <italic>in vitro</italic>. Further investigation of the underlying mechanisms revealed that BANCR markedly activated autophagy. Overexpression of BANCR inhibited apoptosis in the IHH-4 cells, whereas inhibition of autophagy stimulated apoptosis in the BANCR-overexpressed cells. BANCR overexpression also increased cell proliferation and the inhibition of autophagy abrogated BANCR overexpression-induced cell proliferation. In addition, the overexpression of BANCR resulted in an increase in the ratio of LC3-II/LC3-I, a marker for autophagy, while the knockdown of BANCR decreased the ratio of LC3-II/LC3-I. These results revealed that BANCR expression levels are upregulated in PTC. Additionally, BANCR increases PTC cell proliferation, which could activate autophagy.</p></abstract>
<kwd-group>
<kwd>long non-coding RNA</kwd>
<kwd>BRAF-activated long non-coding RNA</kwd>
<kwd>papillary thyroid carcinoma</kwd>
<kwd>autophagy</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for ~80&#x00025; of all thyroid cancers. With appropriate treatment, including surgery and radioiodine ablation, the majority of PTCs have excellent prognoses (<xref rid="b1-ol-08-05-1947" ref-type="bibr">1</xref>). Examining genetic factors could aid early detection and also facilitate the treatment and prevention of PTC. However, the ideal genetic marker for PTC detection has not yet been identified.</p>
<p>Although originally considered to be spurious transcriptional noise, long non-coding RNAs (lncRNAs) are now recognized as regulators in tumorigenesis and tumor progression (<xref rid="b2-ol-08-05-1947" ref-type="bibr">2</xref>,<xref rid="b3-ol-08-05-1947" ref-type="bibr">3</xref>). Functional lncRNAs have the potential to be used for diagnosing cancer and determining prognosis, as well as being a potential therapeutic target that could become a valuable novel diagnostic and therapeutic tool (<xref rid="b4-ol-08-05-1947" ref-type="bibr">4</xref>). BRAF-activated lncRNA (BANCR) is a 693-bp transcript on chromosome 9, which is frequently overexpressed and has a possible functional role in the migration of melanoma cells (<xref rid="b5-ol-08-05-1947" ref-type="bibr">5</xref>,<xref rid="b6-ol-08-05-1947" ref-type="bibr">6</xref>). BANCR is strongly linked with <sup>V600E</sup>BRAF, which is the most prevalent mutation of the BRAF gene. <sup>V600E</sup>BRAF mutations are exhibited in 70&#x00025; of malignant melanomas, 36&#x02013;53&#x00025; of papillary thyroid cancers and 5&#x02013;22&#x00025; of CRCs (<xref rid="b7-ol-08-05-1947" ref-type="bibr">7</xref>). The <sup>V600E</sup>BRAF mutation is considered to be a putative prognostic marker for the aggressiveness of PTC (<xref rid="b8-ol-08-05-1947" ref-type="bibr">8</xref>), but the expression pattern and biological functions of BANCR in PTC remain to be elucidated.</p>
<p>Autophagy is a lysosome-mediated intracellular catabolic process by which cells remove damaged organelles and long-lived proteins to maintain cellular homeostasis (<xref rid="b9-ol-08-05-1947" ref-type="bibr">9</xref>). Autophagy is activated in cancer cells and contributes to tumor cell survival (<xref rid="b10-ol-08-05-1947" ref-type="bibr">10</xref>). High oncogenic BRAF levels have been shown to initiate autophagy, which is possibly involved in tumor progression (<xref rid="b11-ol-08-05-1947" ref-type="bibr">11</xref>). Since a close association exists between the presence of the BRAF gene and autophagy, it has been speculated that BANCR could be involved in the regulation of autophagy.</p>
<p>The aims of the present study were to detect the expression levels of BANCR and to investigate the function and molecular mechanisms of BANCR in PTC.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Tissue samples and cell culture</title>
<p>In total, six specimens of human PTC and adjacent normal tissues were obtained, with informed consent, from surgeries performed between March and June 2013 at the First Affiliated Hospital of Nanjing Medical University (Nanjing, Jiangsu, China). The protocol used in this study was approved by the hospital&#x02019;s Protection of Human Ethics Committee. The diagnosis of PTC was histopathologically confirmed. The resected tissue samples were immediately frozen in liquid nitrogen and stored at &#x02212;80&#x000B0;C until RNA extraction. The human PTC-derived cell line, IHH-4, was provided by Professor Congyou Lu (The Chinese University of Hong Kong, Hong Kong, China). The IHH-4 cells were routinely cultured at 37&#x000B0;C in RPMI 1640 medium (Wisent, Inc., QC, Canada) with 10&#x00025; fetal bovine serum (Wisent, Inc.) and 5&#x00025; carbon dioxide.</p></sec>
<sec>
<title>Quantitative polymerase chain reaction (PCR)</title>
<p>Total RNA from tissues and cells was extracted using RNAiso Plus (Takara Biotechnology (Dalian) Co., Ltd., Dalian, China), and reverse transcription (RT) reactions were performed using a PrimeScript RT reagent kit (Takara Biotechnology (Dalian) Co., Ltd.) according to the manufacturer&#x02019;s instructions. Quantitative PCR reactions were prepared at a final volume of 20 &#x003BC;l using a standard protocol and the SYBR Green PCR kit (Roche Diagnostics Co., Indianapolis, IN, USA), and the reactions were performed on the StepOnePlus Real-Time PCR System (Applied Biosystems, Inc., CA, USA). Each reaction was performed in triplicate. The 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method was used to determine the relative gene expression levels, using &#x003B2;-actin as the endogenous control to normalize the data. The primers used in this study were as follows: BANCR forward, 5&#x02032;-ACAGGACTCCATGGCAAACG-3&#x02032; and reverse, 5&#x02032;-ATGAAGAAAGCCTGGTGCAGT-3&#x02032;; &#x003B2;-actin forward, 5&#x02032;-AGAAAATCTGGCACCAACC-3&#x02032; and reverse, 5&#x02032;-TAGCACAGCCTGGATAGCAA-3&#x02032;; LC3 forward, 5&#x02032;-CCACACCCAAAGTCCTCACT-3&#x02032; and reverse, 5&#x02032;-CAC TGCTGCTTTCCGTAACA-3&#x02032;. PCR was performed at 95&#x000B0;C for 30 sec, 40 cycles of 95&#x000B0;C for 5 sec, 60&#x000B0;C for 31 sec, and then, for dissociation, at 95&#x000B0;C for 15 sec, 60&#x000B0;C for 1 min and 95&#x000B0;C for 15 sec.</p></sec>
<sec>
<title>Generation of stable infected cell lines</title>
<p>Recombinant lentiviruses containing short hairpin (sh)RNA-323 (LV-BANCR-323, GGA GTGGCGACTATAGCAAAC), shRNA-540 (LV-BANCR-540, GGACTCCATGGCAAACGTTGT), human full-length BANCR cDNA (LV-BANCR) and a negative control (LV-NC) were purchased from GenePharma Co., Ltd. (Shanghai, China). The IHH-4 cells were infected with LV-BANCR-323, LV-BANCR-540, LV-BANCR and LV-NC (multiplicity of infection, 20). The supernatant was removed after 24 h and fresh culture medium was added to the cells. The infection efficiency was confirmed by RT-PCR at 72 h post-infection, and the cells were treated with 2 &#x003BC;g/ml puromycin for 2 weeks.</p></sec>
<sec>
<title>Cell proliferation assays</title>
<p>Cell proliferation assays were performed using Cell Counting Kit-8 (CCK8; Beyotime Institute of Biotechnology, Jiangsu, China). The cells were plated in triplicate in 96-well plates at ~2&#x000D7;10<sup>3</sup> cells per well and cultured in the growth medium. The number of cells per well was measured by the absorbance at 450 nm at the indicated time<italic>-</italic>points, according to the manufacturer&#x02019;s instructions.</p></sec>
<sec>
<title>Flow cytometric analysis</title>
<p>The cells (4&#x000D7;10<sup>5</sup>) were seeded in 6-well plates. After 24 h, the cells were collected and incubated with Annexin V-fluorescein isothiocyanate and 7-amino-actinomycin D (Biolegend, Inc., San Diego, CA, USA) for 15 min in the dark and apoptosis was analyzed using a flow cytometer. The cell cycle was also analyzed subsequent to propidium iodide staining for 30 min.</p></sec>
<sec>
<title>Transwell migration assay</title>
<p>In total, 4&#x000D7;10<sup>4</sup> cells were plated in medium without serum on a non-coated membrane in the top chamber (24-well insert; 8-mm pore size; Corning Costar; Corning, Inc., Corning, NY, USA). Medium supplemented with serum was used as a chemotactic agent in the lower chamber. The cells were incubated for 24 h, and those cells that did not migrate through the pores were removed with a cotton swab. The cells on the lower surface of the membrane were stained with crystal violet (Beijing Solarbio Science &amp; Technology Co., Ltd., Beijing, China). The cell numbers were determined by counting the penetrating cells under a microscope (Nikon, Kobe, Japan) in random fields, with five fields per chamber. Each experiment was performed in triplicate.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Proteins were extracted with radioimmunoprecipitation assay (Beyotime Institute of Biotechnology) and equal amounts of protein were electrophoresed on a 12 or 15&#x00025; sodium dodecyl sulfate-polyacrylamide gel and subsequently transferred to polyvinylidene fluoride membranes (Millipore, Boston, MA, USA). The membranes were blocked with 5&#x00025; skimmed milk in Tris-buffered saline containing 0.1&#x00025; Tween-20 (TBST), at room temperature for 2 h. The membranes were incubated with the rabbit polyclonal LC3-I, LC3-II (1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA) and rabbit polyclonal GAPDH (1:10,000; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China) primary antibodies at 4&#x000B0;C overnight. The membranes were then washed three times with TBST and incubated with horseradish peroxidase-conjugated secondary anti-rabbit antibody (1:5,000; Beijing Biosynthesis Biotechnology Co., Ltd.) at room temperature for 2 h. Following three washes with TBST, the membranes were developed using ECL Plus (EMD Millipore, Billerica, MA, USA), and exposed to X-ray film. GAPDH was used as an internal loading control.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Data were analyzed using SPSS 19.0 software (SPSS, Chicago, IL, USA), and are expressed as the mean &#x000B1; standard deviation of data from at least three independent experiments. The differences between the groups were analyzed using Student&#x02019;s t-test, Pearson&#x02019;s &#x003C7;<sup>2</sup>-test or one-way analysis of variance, as appropriate. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>BANCR levels are significantly upregulated in PTC</title>
<p>To investigate the role of BANCR in PTC development, BANCR RNA expression levels in PTC tissue samples were examined first. The RT-PCR results showed that BANCR expression was significantly higher in five out of six of the tumor tissues compared with the adjacent normal tissues. Additionally, BANCR expression in the PTC IHH-4 cell line was upregulated compared with the mean expression level of the adjacent normal tissues (P&lt;0.05; <xref rid="f1-ol-08-05-1947" ref-type="fig">Fig. 1</xref>).</p></sec>
<sec>
<title>BANCR-knockdown inhibits proliferation and increases apoptosis of PTC IHH-4 cells</title>
<p>Following infection with LV-BANCR-323 and LV-BANCR-540, the BANCR expression level was significantly downregulated compared with the LV-NC (P&lt;0.05; <xref rid="f2-ol-08-05-1947" ref-type="fig">Fig. 2A</xref>). As shown in <xref rid="f2-ol-08-05-1947" ref-type="fig">Fig. 2C</xref>, the knockdown of BANCR induced cell apoptosis. The results were presented as the percentage of apoptotic cells in the total number of counted cells. Signals from apoptotic cells were localized in the lower right quadrant (F=603.832, P&lt;0.05). The CCK8 assays revealed that the knockdown of BANCR inhibited the proliferation of the IHH-4 cells (P&lt;0.05; <xref rid="f2-ol-08-05-1947" ref-type="fig">Fig. 2B</xref>). Further investigation into the role of BANCR in the regulation of cell proliferation revealed that the knockdown of BANCR resulted in an increase in the cell population in the G<sub>1</sub> phase (P&lt;0.05; <xref rid="f2-ol-08-05-1947" ref-type="fig">Fig. 2D</xref>). The Transwell migration assays showed that BANCR-knockdown had no significant effect on the migration of the IHH-4 cells (P&gt;0.05; <xref rid="f2-ol-08-05-1947" ref-type="fig">Fig. 2E</xref>).</p></sec>
<sec>
<title>Overexpression of BANCR increases autophagy activation in PTC IHH-4 cells</title>
<p>To explore the mechanism by which BANCR regulates cell proliferation, the present study investigated whether BANCR regulates cell autophagy. The IHH-4 cells were treated with LV-BANCR, with or without 3-methyladenine (3-MA), an inhibitor of autophagy. The results revealed that following infection with LV-BANCR, the BANCR expression level was significantly upregulated compared with the LV-NC (P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3A</xref>). The overexpression of BANCR inhibited the apoptosis of the IHH-4 cells, promoted cell growth and decreased the cell population in the G<sub>1</sub> phase, whereas autophagy inhibition increased cell apoptosis (F=167.557, P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3C</xref>), inhibited cell growth (P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3B</xref>) and increased G<sub>1</sub> arrest (P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3D</xref>) in the BANCR-overexpressed IHH-4 cells. The western blotting results demonstrated that BANCR overexpression resulted in an increase in the ratio of LC3-II/LC3-I, a marker for autophagy, while knockdown of BANCR and treatment with 3-MA decreased the ratio of LC3-II/LC3-I (P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3E</xref>). The RT-PCR results indicated that the level of LC3 mRNA had increased in the BANCR-overexpressed cells, while it had decreased following BANCR-knockdown and in the 3-MA-treated cells (P&lt;0.05; <xref rid="f3-ol-08-05-1947" ref-type="fig">Fig. 3F</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Advances in molecular techniques have led to the identification of a novel type of gene regulators called lncRNA. These lncRNAs are &gt;200 nucleotides and do not code for proteins. However, they can interact with proteins and can likely act as regulators of other genes (<xref rid="b12-ol-08-05-1947" ref-type="bibr">12</xref>). Although lncRNAs are not as well-characterized as small non-coding microRNAs, they play a critical role in the regulation of diverse cellular processes (<xref rid="b13-ol-08-05-1947" ref-type="bibr">13</xref>,<xref rid="b14-ol-08-05-1947" ref-type="bibr">14</xref>). In thyroid cancer, one such example of oncogenic lncRNA is papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3). Using quantitative PCR, PTCSC3 expression was revealed to be strongly downregulated in thyroid tumor tissues, and it was demonstrated that the restoration of PTCSC3 expression in PTC cells inhibited cell growth and affected the expression of numerous genes (<xref rid="b15-ol-08-05-1947" ref-type="bibr">15</xref>). Another classic oncogenic lncRNA is non-coding RNA associated with the mitogen-activated protein (MAP) kinase pathway and growth arrest (NAMA), which is weakly expressed in thyroid cancer tissues. Knockdown of BRAF has been revealed to induce inhibition of the MAP kinase pathway, growth arrest and DNA damage in thyroid cancer cell lines (<xref rid="b16-ol-08-05-1947" ref-type="bibr">16</xref>).</p>
<p>BANCR is recurrently overexpressed in melanoma. In previous studies, shRNA-mediated knockdown of BANCR in melanoma cells was revealed to alter the expression levels of 88 genes, several of which are involved in cell migration and chemotaxis. BANCR depletion impaired the migration of the melanoma cells <italic>in vitro</italic> (<xref rid="b5-ol-08-05-1947" ref-type="bibr">5</xref>,<xref rid="b6-ol-08-05-1947" ref-type="bibr">6</xref>). Mutation of BRAF is hypothesized to be a putative prognostic marker for the aggressiveness of PTC (<xref rid="b17-ol-08-05-1947" ref-type="bibr">17</xref>). Based on these findings, it was hypothesized that BANCR could play a critical role in PTC. In the present study, it was found that BANCR expression levels were upregulated in five out of six PTC tumor tissues compared with their adjacent normal tissues. Although samples from only six patients were used in the present study and the results may not be entirely accurate due to type I or II errors, the present data suggest a possible oncogenic role of BANCR in several human cancers. Furthermore, <italic>in vitro</italic> examination of the potential role of BANCR in PTC IHH-4 cells demonstrated that the knockdown of BANCR in the IHH-4 cells was associated with the inhibition of proliferation and the promotion of apoptosis, but exhibited no significant effect on cell migration. This observation was in contrast with previous studies regarding the role of BANCR in regulating cell migration (<xref rid="b5-ol-08-05-1947" ref-type="bibr">5</xref>), thereby suggesting that the function of BANCR could be tissue-specific.</p>
<p>Autophagy is a self-degradative process through which the cytoplasmic materials within the lysosome are degraded. The process acts as a dynamic system that provides the building blocks of a cell and the energy for cellular homeostasis and regeneration (<xref rid="b18-ol-08-05-1947" ref-type="bibr">18</xref>). Maddodi <italic>et al</italic> observed that the presence of high levels of mBRAF triggers the hyperactivation of extracellular-signal-regulated kinase (ERK), a senescence-like phenotype and initiates autophagy through the inhibition of mammalian target of rapamycin complex signaling (<xref rid="b11-ol-08-05-1947" ref-type="bibr">11</xref>). BANCR was considered to play a role in controlling cell proliferation by regulating autophagy activation, although there was no direct evidence to support this hypothesis. In the present study, it was demonstrated that the overexpression of BANCR induced autophagy activation, whereas BANCR-knockdown decreased autophagy activation in the PTC IHH-4 cells. Autophagy activation was evaluated by observing the ratio of LC3-II/LC3-I. Overexpression of BANCR inhibited the apoptosis of the IHH-4 cells, promoted cell growth and decreased the cell population in the G<sub>1</sub> phase; all these effects could be suppressed by 3-MA, an inhibitor of autophagy. These findings suggest that BANCR may increase PTC cell proliferation by activating autophagy.</p>
<p>To the best of our knowledge, this is the first study to report that BANCR is highly expressed in PTC and that BANCR is likely to be a useful biomarker of this disease. Additionally, the fact that BANCR increases PTC cell proliferation by activating autophagy adds to our understanding of the molecular mechanisms governing BANCR. Significantly, BANCR could be used as a potential molecular target to treat human PTC.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was funded by the &#x02018;333 project&#x02019; of Jiangsu Province (grant no. BK20131448).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ol-08-05-1947"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>SI</given-names></name></person-group><article-title>Thyroid carcinoma</article-title><source>Lancet</source><volume>361</volume><fpage>501</fpage><lpage>511</lpage><year>2003</year></element-citation></ref>
<ref id="b2-ol-08-05-1947"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Endo</surname><given-names>H</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name><etal/></person-group><article-title>Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer</article-title><source>Biochem Biophys Res Commun</source><volume>436</volume><fpage>319</fpage><lpage>324</lpage><year>2013</year></element-citation></ref>
<ref id="b3-ol-08-05-1947"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>PC</given-names></name></person-group><article-title>Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression</article-title><source>Biochem Biophys Res Commun</source><volume>432</volume><fpage>612</fpage><lpage>617</lpage><year>2013</year></element-citation></ref>
<ref id="b4-ol-08-05-1947"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>X</given-names></name></person-group><article-title>The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine</article-title><source>Mod Pathol</source><volume>26</volume><fpage>155</fpage><lpage>165</lpage><year>2013</year></element-citation></ref>
<ref id="b5-ol-08-05-1947"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flockhart</surname><given-names>RJ</given-names></name><name><surname>Webster</surname><given-names>DE</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><etal/></person-group><article-title>BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration</article-title><source>Genome Res</source><volume>22</volume><fpage>1006</fpage><lpage>1014</lpage><year>2012</year></element-citation></ref>
<ref id="b6-ol-08-05-1947"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>N</given-names></name></person-group><article-title>Epigenetics. Going places with BANCR</article-title><source>Nat Rev Cancer</source><volume>12</volume><fpage>451</fpage><year>2012</year></element-citation></ref>
<ref id="b7-ol-08-05-1947"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Bignell</surname><given-names>GR</given-names></name><name><surname>Cox</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mutations of the BRAF gene in human cancer</article-title><source>Nature</source><volume>417</volume><fpage>949</fpage><lpage>954</lpage><year>2002</year></element-citation></ref>
<ref id="b8-ol-08-05-1947"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>GM</given-names></name><name><surname>Nikiforova</surname><given-names>MN</given-names></name><name><surname>Carty</surname><given-names>SE</given-names></name><etal/></person-group><article-title>BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer</article-title><source>Ann Surg Oncol</source><volume>20</volume><fpage>47</fpage><lpage>52</lpage><year>2013</year></element-citation></ref>
<ref id="b9-ol-08-05-1947"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amelio</surname><given-names>I</given-names></name><name><surname>Melino</surname><given-names>G</given-names></name><name><surname>Knight</surname><given-names>RA</given-names></name></person-group><article-title>Cell death pathology: cross-talk with autophagy and its clinical implications</article-title><source>Biochem Biophys Res Commun</source><volume>414</volume><fpage>277</fpage><lpage>281</lpage><year>2011</year></element-citation></ref>
<ref id="b10-ol-08-05-1947"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>WX</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>XM</given-names></name></person-group><article-title>Tumor cells can evade dependence on autophagy through adaptation</article-title><source>Biochem Biophys Res Commun</source><volume>425</volume><fpage>684</fpage><lpage>688</lpage><year>2012</year></element-citation></ref>
<ref id="b11-ol-08-05-1947"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddodi</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Havighurst</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Longley</surname><given-names>BJ</given-names></name><name><surname>Setaluri</surname><given-names>V</given-names></name></person-group><article-title>Induction of autophagy and inhibition of melanoma growth <italic>in vitro</italic> and <italic>in vivo</italic> by hyperactivation of oncogenic BRAF</article-title><source>J Invest Dermatol</source><volume>130</volume><fpage>1657</fpage><lpage>1667</lpage><year>2010</year></element-citation></ref>
<ref id="b12-ol-08-05-1947"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>YQ</given-names></name></person-group><article-title>Long noncoding RNAs: new regulators in plant development</article-title><source>Biochem Biophys Res Commun</source><volume>436</volume><fpage>111</fpage><lpage>114</lpage><year>2013</year></element-citation></ref>
<ref id="b13-ol-08-05-1947"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name></person-group><article-title>Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression</article-title><source>Cancer Lett</source><volume>333</volume><fpage>213</fpage><lpage>221</lpage><year>2013</year></element-citation></ref>
<ref id="b14-ol-08-05-1947"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Long noncoding RNAs: new players in prostate cancer</article-title><source>Cancer Lett</source><volume>339</volume><fpage>8</fpage><lpage>14</lpage><year>2013</year></element-citation></ref>
<ref id="b15-ol-08-05-1947"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells</article-title><source>Exp Ther Med</source><volume>5</volume><fpage>1143</fpage><lpage>1146</lpage><year>2013</year></element-citation></ref>
<ref id="b16-ol-08-05-1947"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Nagy</surname><given-names>R</given-names></name><etal/></person-group><article-title>Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest</article-title><source>Int J Cancer</source><volume>121</volume><fpage>767</fpage><lpage>775</lpage><year>2007</year></element-citation></ref>
<ref id="b17-ol-08-05-1947"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Condouris</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>M</given-names></name></person-group><article-title>BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells</article-title><source>J Clin Endocrinol Metab</source><volume>92</volume><fpage>2264</fpage><lpage>2271</lpage><year>2007</year></element-citation></ref>
<ref id="b18-ol-08-05-1947"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Kuang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?</article-title><source>Cancer Lett</source><volume>323</volume><fpage>115</fpage><lpage>127</lpage><year>2012</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ol-08-05-1947" position="float">
<label>Figure 1</label>
<caption>
<p>BANCR levels are upregulated in papillary thyroid carcinoma (PTC). Reverse transcription-polymerase chain reaction results showed that BANCR expression was significantly higher in five out of six of the tumor tissues compared with the adjacent normal tissues. The BANCR level in the PTC IHH-4 cell line was also upregulated compared with the mean expression level of the adjacent normal tissues. BANCR expression levels were normalized to &#x003B2;-actin. Data are presented as the mean &#x000B1; standard deviation (<sup>*</sup>P&lt;0.05). BANCR, BRAF-activated long non-coding RNA; N, normal tissue; T, tumorous tissue.</p></caption>
<graphic xlink:href="OL-08-05-1947-g00.gif"/></fig>
<fig id="f2-ol-08-05-1947" position="float">
<label>Figure 2</label>
<caption>
<p>BANCR-knockdown inhibits cell proliferation and increases apoptosis in papillary thyroid carcinoma IHH-4 cells. (A) Following treatment with LV-BANCR-323 and LV-BANCR-540, BANCR expression in the IHH-4 cells was downregulated compared with the cells treated with LV-NC. (B) Cell Counting Kit-8 assays showed that BANCR-knockdown inhibited the proliferation of the IHH-4 cells. (C) Knockdown of BANCR induced apoptosis, which was detected by flow cytometry. The results are presented as the percentage of apoptotic cells in the total number of counted cells. (D) BANCR-knockdown resulted in an increase in the cell population in the G<sub>1</sub> phase. The data represent one of at least three independent experiments. (E) The Transwell migration assays showed that BANCR-knockdown had no significant effect on the migration of IHH-4 cells. The images represent at least three independent experiments. The graph indicates the number of migrated cells per field. The results are presented as the mean &#x000B1; standard deviation (<sup>*</sup>P&lt;0.05). BANCR, BRAF-activated long non-coding RNA; LV-BANCR-323, lentivirus containing shRNA-323; LV-BANCR-540, lentivirus containing short haipin (sh)RNA-540; LV-NC, lentivirus negative control; 7-AAD, 7-amino-actinomycin D; FITC, fluorescein isothiocyanate.</p></caption>
<graphic xlink:href="OL-08-05-1947-g01.gif"/></fig>
<fig id="f3-ol-08-05-1947" position="float">
<label>Figure 3</label>
<caption>
<p>Overexpression of BANCR increases autophagy activation in papillary thyroid carcinoma IHH-4 cells.(A) Following treatment with LV-BANCR, BANCR expression in IHH-4 cells was upregulated compared with the cells treated with LV-NC. (B) Cell Counting Kit-8 assays showed that the overexpression of BANCR promoted cell growth, whereas the inhibition of autophagy inhibited the proliferation of the IHH-4 cells. (C) Overexpression of BANCR inhibited cell apoptosis, whereas autophagy inhibition increased apoptosis in the IHH-4 cells, which was detected by flow cytometry. (D) Overexpression of BANCR decreased the cell population in the G<sub>1</sub> phase, whereas autophagy inhibition increased the cell population in the G<sub>1</sub> phase. The data represent one of at least three independent experiments. (E) Western blotting results revealed that BANCR overexpression resulted in an increase in the ratio of LC3-II/LC3-I, while knockdown of BANCR and treatment with 3-MA decreased the ratio of LC3-II/LC3-I. (F) Reverse transcription polymerase chain reaction results showed that BANCR overexpression resulted in an increase in the LC3 mRNA level, while knockdown of BANCR and treatment with 3-MA decreased LC3 mRNA level. The results are presented as the mean &#x000B1; standard deviation (<sup>*</sup>P&lt;0.05). BANCR, BRAF-activated long non-coding RNA; LV-BANCR, lentivirus containing human full-length BANCR cDNA; LV-BANCR-323, LV containing short hairpin (sh)RNA-323; LV-BANCR-540, LV containing shRNA-540; LV-NC, LV negative control; 3-MA, 3-methyladenine; 7-AAD, 7-amino-actinomycin D; FITC, fluorescein isothiocyanate.</p></caption>
<graphic xlink:href="OL-08-05-1947-g02.gif"/></fig></floats-group></article>
